Wie hoch ist der Preis für DelMar Pharmaceuticals, Inc. (DMPWW)

Preis für DelMar Pharmaceuticals, Inc. (DMPWW) ist $0.005

Wie hoch ist die Marktkapitalisierung für DelMar Pharmaceuticals, Inc. (DMPWW)

Marktkapitalisierung für DelMar Pharmaceuticals, Inc. (DMPWW) ist $1.74K

DelMar Pharmaceuticals, Inc. (DMPWW) Preis und Marktkapitalisierung

Kintara Therapeutics, Inc., previously known as DelMar Pharmaceuticals, Inc. until its rebranding in August 2020, operates as a clinical-stage pharmaceutical firm. Headquartered in San Diego, California, and established in 2009, the company is committed to advancing and bringing to market anti-cancer treatments for patients. Its development pipeline includes two advanced therapeutic candidates. One is VAL-083, a DNA-targeting agent poised for Phase III trials, designed to combat various drug-resistant solid tumors such as glioblastoma multiforme, ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The other is REM-001, a late-stage photodynamic therapy intended for conditions like cutaneous metastatic breast cancer, basal cell carcinoma nevus syndrome, and addressing access graft failure in hemodialysis patients. Kintara Therapeutics also maintains a strategic alliance with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. for the manufacturing and commercialization of VAL-083 within the Chinese market.

Preis für DMPWW	Vermögenswert B	Marktkapitalisierung von B	Ergebnisse
$15,599,990 $1.74K	NVDA	$5.426T	+311,999,799,996.77%
$12,756,320 $1.74K	AAPL	$4.437T	+255,126,408,619.45%
$11,924,287 $1.74K	GOOG	$4.148T	+238,485,730,593.06%
$10,533,726 $1.74K	MSFT	$3.664T	+210,674,522,670.40%
$8,306,738 $1.74K	AMZN	$2.889T	+166,134,752,875.68%

Preis für DMPWW

Vermögenswert B

Marktkapitalisierung von B

Ergebnisse

$15,599,990 $1.74K